Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Veradermics has the lowest figure of the 61 pharmaceuticals ranked by total liabilities, at ZAR 157.9M, followed by Belite Bio (ZAR 173.6M) and Oruka Therapeutics (ZAR 287.7M). Figures as of 18 Nov 2026, 16:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsZAR 157.9M
- Median
- ZAR 35.9B
- Combined market value
- ZAR 87.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | ZAR 157.9M | ZAR 90.8B | ZAR 2,150.96 | 0.71% down | 233% up | ||
| 2 | Belite BioBLTE · Health Care | ZAR 173.6M | ZAR 111.5B | ZAR 2,744.27 | 0.91% up | 31% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | ZAR 287.7M | ZAR 113B | ZAR 1,666.46 | 0.34% up | 241% up | ||
| 4 | Edgewise TherapeuticsEWTX · Health Care | ZAR 523.2M | ZAR 77B | ZAR 703.09 | 3.00% down | 88% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | ZAR 646.9M | ZAR 83.9B | ZAR 1,490.33 | 0.63% down | 113% up | ||
| 6 | Protagonist TherapeuticsPTGX · Health Care | ZAR 922.1M | ZAR 140.3B | ZAR 2,149.41 | 0.01% down | 46% up | ||
| 7 | Praxis Precision MedicinesPRAX · Health Care | ZAR 1B | ZAR 147.2B | ZAR 5,265.42 | 0.10% up | 61% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | ZAR 1.1B | ZAR 155.8B | ZAR 1,640.08 | 1.40% up | 286% up | ||
| 9 | ErascaERAS · Health Care | ZAR 1.2B | ZAR 80.2B | ZAR 228.46 | 4.61% down | 403% up | ||
| 10 | Summit TherapeuticsSMMT · Health Care | ZAR 1.6B | ZAR 149.6B | ZAR 187.08 | 1.69% up | 36% down | ||
| 11 | Definium TherapeuticsDFTX · Health Care | ZAR 1.9B | ZAR 67.2B | ZAR 491.23 | 3.03% down | 169% up | ||
| 12 | ABIVAXABVX · Health Care | ZAR 2.5B | ZAR 126.3B | ZAR 1,442.22 | 1.88% up | 27% down | ||
| 13 | Corcept TherapeuticsCORT · Health Care | ZAR 3.3B | ZAR 129.6B | ZAR 1,183.93 | 2.01% down | 8% down | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 3.4B | ZAR 130.4B | ZAR 1,659.39 | 1.19% up | 126% up | ||
| 15 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 3.6B | ZAR 139.5B | ZAR 2,011.90 | 0.06% up | 13% up | ||
| 16 | Cogent BiosciencesCOGT · Health Care | ZAR 5.2B | ZAR 85.8B | ZAR 493.19 | 2.71% up | 20% down | ||
| 17 | TG TherapeuticsTGTX · Health Care | ZAR 7.2B | ZAR 167B | ZAR 1,105.05 | 2.20% up | 107% up | ||
| 18 | Roivant SciencesROIV · Health Care | ZAR 7.2B | ZAR 485.2B | ZAR 669.69 | 0.34% up | 90% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | ZAR 8.5B | ZAR 83.3B | ZAR 867.45 | 1.55% down | 44% up | ||
| 20 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 9.1B | ZAR 103.1B | ZAR 1,579.13 | 0.40% down | 31% up | ||
| 21 | Ligand PharmaceuticalsLGND · Health Care | ZAR 9.4B | ZAR 103.4B | ZAR 5,168.26 | 2.02% up | 43% up | ||
| 22 | Axsome TherapeuticsAXSM · Health Care | ZAR 10.4B | ZAR 121.2B | ZAR 2,303.38 | 1.74% down | 7% down | ||
| 23 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 11.3B | ZAR 164.9B | ZAR 7,100.85 | 2.41% down | 24% down | ||
| 24 | AlkermesALKS · Health Care | ZAR 11.5B | ZAR 135.2B | ZAR 804.52 | 2.66% up | 58% up | ||
| 25 | Legend BiotechLEGN · Health Care | ZAR 12.6B | ZAR 54.2B | ZAR 279.58 | 0.65% up | 42% down | ||
| 26 | United TherapeuticsUTHR · Health Care | ZAR 13.5B | ZAR 421.7B | ZAR 9,902.44 | 1.68% down | 23% up | ||
| 27 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 15.2B | ZAR 105.9B | ZAR 749.17 | 1.07% up | 10% up | ||
| 28 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 26B | ZAR 201B | ZAR 1,037.81 | 2.87% up | 11% up | ||
| 29 | InsmedINSM · Health Care | ZAR 26.3B | ZAR 453.9B | ZAR 2,069.23 | 1.52% down | 40% down | ||
| 30 | Ascendis PharmaASND · Health Care | ZAR 28B | ZAR 305.9B | ZAR 4,663.32 | 0.27% down | 28% up | ||
| 31 | CytokineticsCYTK · Health Care | ZAR 35.9B | ZAR 123.1B | ZAR 883.83 | 0.76% down | 20% down | ||
| 32 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 36.5B | ZAR 215.4B | ZAR 258.37 | 1.32% up | 5% up | ||
| 33 | BridgeBio PharmaBBIO · Health Care | ZAR 51.9B | ZAR 261.8B | ZAR 1,344.07 | 1.50% up | 17% up | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | ZAR 52.3B | ZAR 78.3B | ZAR 470.37 | 1.19% up | 64% down | ||
| 35 | PTC TherapeuticsPTCT · Health Care | ZAR 53.5B | ZAR 87.2B | ZAR 1,044.01 | 0.31% up | 20% down | ||
| 36 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 63.3B | ZAR 129.9B | ZAR 372.78 | 2.37% up | 83% up | ||
| 37 | BeOne MedicinesONC · Health Care | ZAR 66B | ZAR 796.8B | ZAR 6,975.67 | 2.10% down | 17% up | ||
| 38 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 72B | ZAR 354.1B | ZAR 2,643.66 | 2.03% down | 66% down | ||
| 39 | Elanco Animal HealthELAN · Health Care | ZAR 117.4B | ZAR 227.7B | ZAR 455.54 | 2.21% up | 20% up | ||
| 40 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 120.3B | ZAR 2.34T | ZAR 9,223.19 | 0.13% up | 27% up | ||
| 41 | GenmabGMAB · Health Care | ZAR 121.1B | ZAR 547B | ZAR 887.11 | 0.98% down | 70% up | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 126.6B | ZAR 269.8B | ZAR 4,203.13 | 1.27% up | 37% up | ||
| 43 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 160.4B | ZAR 1.7T | ZAR 16,478.18 | 0.22% down | 36% up | ||
| 44 | Royalty PharmaRPRX · Health Care | ZAR 170.8B | ZAR 679.5B | ZAR 1,181.78 | 0.20% down | 78% up | ||
| 45 | ZoetisZTS · Health Care | ZAR 209.3B | ZAR 588.1B | ZAR 1,447.39 | 0.56% up | 29% down | ||
| 46 | GrifolsGRFS · Health Care | ZAR 231.6B | ZAR 100.4B | ZAR 147.51 | 0.87% down | 1% up | ||
| 47 | ViatrisVTRS · Health Care | ZAR 387.6B | ZAR 409.9B | ZAR 357.52 | 1.39% up | 96% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 566.1B | ZAR 853.4B | ZAR 731.41 | 0.47% down | 74% up | ||
| 49 | Abbott LaboratoriesABT · Health Care | ZAR 585.2B | ZAR 3.11T | ZAR 1,795.51 | 0.55% down | 17% down | ||
| 50 | Takeda PharmaceuticalTAK · Health Care | ZAR 872.6B | ZAR 1.18T | ZAR 368.55 | 1.22% down | 54% up | ||
| 51 | Novo NordiskNVO · Health Care | ZAR 892.6B | ZAR 3.02T | ZAR 685.46 | 2.32% down | 17% down | ||
| 52 | GSKGSK · Health Care | ZAR 1.03T | ZAR 1.69T | ZAR 842.63 | 0.75% down | 6% up | ||
| 53 | SanofiSNY · Health Care | ZAR 1.05T | ZAR 1.96T | ZAR 815.38 | 0.50% down | 4% down | ||
| 54 | NovartisNVS · Health Care | ZAR 1.11T | ZAR 5.09T | ZAR 2,695.13 | 1.77% down | 25% up | ||
| 55 | AstraZenecaAZN · Health Care | ZAR 1.13T | ZAR 4.79T | ZAR 3,087.47 | 1.76% down | 2% up | ||
| 56 | Bristol-Myers SquibbBMY · Health Care | ZAR 1.23T | ZAR 2.11T | ZAR 1,032.81 | 2.36% down | 34% up | ||
| 57 | Merck & CoMRK · Health Care | ZAR 1.45T | ZAR 5.93T | ZAR 2,406.84 | 2.64% down | 51% up | ||
| 58 | Eli LillyLLY · Health Care | ZAR 1.48T | ZAR 21.34T | ZAR 23,955.25 | 1.85% down | 35% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | ZAR 2.03T | ZAR 11.42T | ZAR 4,744.88 | 1.26% down | 38% up | ||
| 60 | PfizerPFE · Health Care | ZAR 2.09T | ZAR 2.77T | ZAR 485.80 | 1.04% down | 14% up | ||
| 61 | AbbVieABBV · Health Care | ZAR 2.37T | ZAR 8.79T | ZAR 4,972.90 | 1.50% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2422 ZAR).
Questions and answers
Which pharmaceuticals have the lowest total liabilities?
Veradermics (ZAR 157.9M), Belite Bio (ZAR 173.6M) and Oruka Therapeutics (ZAR 287.7M) have the lowest total liabilities of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 16:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of ZAR 87.7T as of 18 Nov 2026, 16:06 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.